Nuveen
ASTH icon

Nuveen’s Astrana Health ASTH Stock Holding History

Nuveen’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.16M Buy
132,822
+46,685
+54% +$1.68M ﹤0.01% 1973
2026
Q1 		$2.11M Buy
86,137
+538
+0.6% +$12.7K ﹤0.01% 2258
2025
Q4 		$2.12M Sell
85,599
-2,773
-3% -$73.6K ﹤0.01% 2270
2025
Q3 		$2.51M Hold
88,372
– – ﹤0.01% 2211
2025
Q2 		$2.2M Sell
88,372
-20,266
-19% -$571K ﹤0.01% 2264
2025
Q1 		$3.37M Hold
108,638
– – ﹤0.01% 2115
2024
Q4 		$3.43M Sell
108,638
-1,924
-2% -$91.4K ﹤0.01% 2148
2024
Q3 		$6.41M Hold
110,562
– – ﹤0.01% 1874
2024
Q2 		$4.48M Buy
110,562
+2,767
+3% +$110K ﹤0.01% 2007
2024
Q1 		$4.53M Sell
107,795
-2,723
-2% -$106K ﹤0.01% 2039
2023
Q4 		$4.23M Buy
110,518
+2,688
+2% +$89.5K ﹤0.01% 2074
2023
Q3 		$3.33M Sell
107,830
-740
-0.7% -$25.5K ﹤0.01% 2063
2023
Q2 		$3.43M Sell
108,570
-13,374
-11% -$459K ﹤0.01% 2096
2023
Q1 		$4.45M Sell
121,944
-18,983
-13% -$665K ﹤0.01% 1961
2022
Q4 		$4.17M Sell
140,927
-12,401
-8% -$399K ﹤0.01% 2017
2022
Q3 		$5.98M Sell
153,328
-172
-0.1% -$7.87K ﹤0.01% 1796
2022
Q2 		$5.92M Buy
153,500
+10,675
+7% +$406K ﹤0.01% 1836
2022
Q1 		$6.8M Buy
142,825
+35,323
+33% +$1.82M ﹤0.01% 1888
2021
Q4 		$7.69M Sell
107,502
-10,384
-9% -$853K ﹤0.01% 1846
2021
Q3 		$11.4M Sell
117,886
-12,753
-10% -$1.08M ﹤0.01% 1689
2021
Q2 		$8.21M Buy
130,639
+40,992
+46% +$1.52M ﹤0.01% 1985
2021
Q1 		$2.43M Buy
89,647
+2,225
+3% +$53.5K ﹤0.01% 2530
2020
Q4 		$1.6M Buy
87,422
+6,736
+8% +$121K ﹤0.01% 2617
2020
Q3 		$1.45M Buy
80,686
+20,664
+34% +$356K ﹤0.01% 2512
2020
Q2 		$990K Buy
60,022
+2,322
+4% +$36.5K ﹤0.01% 2629
2020
Q1 		$745K Buy
57,700
+8,167
+16% +$133K ﹤0.01% 2633
2019
Q4 		$912K Sell
49,533
-57,878
-54% -$960K ﹤0.01% 2720
2019
Q3 		$1.89M Buy
107,411
+60,445
+129% +$1.03M ﹤0.01% 2425
2019
Q2 		$785K Buy
+46,966
New +$853K ﹤0.01% 2833

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen's ASTH Position: Q2 2026 in Review

Nuveen increased its Astrana Health (ASTH) stake by 54% in Q2 2026, buying an estimated $1.68M and bringing the position to 132,822 shares worth $6.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

Nuveen first reported a position in ASTH in Q2 2019 and has held it in 29 quarters since. The position peaked at $11.4M in Q3 2021. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Nuveen held 132,822 shares of Astrana Health worth $6.16M as of Q2 2026.
  • Nuveen bought 46,685 Astrana Health shares in Q2 2026, an estimated $1.68M.
  • Astrana Health made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1973 holding.
  • Nuveen first reported a position in Astrana Health in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Astrana Health position peaked at $11.4M in Q3 2021.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.